Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

Vaccine

Volumn 15, Issue 5, 1997, Pages 525-532

  Neuzil, Kathleen M ^a   Johnson, Joyce E ^a   Tang, Yi Wei ^a   Prieels, Jean Paul ^b   Slaoui, Moncef ^b   Gar, Natalie ^b   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

adjuvants; immunization; respiratory syncytial virus

Indexed keywords

ALPHA TUBULIN; ALUMINUM POTASSIUM SULFATE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHORYL LIPID A; QS 21; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INFLAMMATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS CULTURE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030887353     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00218-1     Document Type: Article

References (29)

1. Hall, C.B., Walsh, E.E., Long, C.E. and Schnabel, K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 1991, 163, 693-698
2. Chin, J., Magoffin, R., Shearer, L, Schieble, J. and Lennette, E. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 1969, 89, 449-463
3. Fulginiti, V., Eller, J. and Sieber, O. et al. Respiratory virus immunization-A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 1969, 89, 435-440
4. Kapikian, A., Mitchell, R., Chanock, R., Shevedoff, R. and Stewart, C. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89, 405-421
5. Kim, H.W., Arroio, J.O. and Pyles, G. et al. Clinical and immunologic response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 1968, 48, 745-755
6. Belshe, R., Voris, L.V. and Mufson, M. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 1982, 145, 311-319
7. Kim, H., Canchola, J. and Brandt, C. et al. Respiratory syncytial disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89, 422-434
8. Wright, P., Shinozaki, T., Fleet, W., Sell, S.H., Thompson, J. and Karzon, D.T. Evaluation of a live attenuated respiratory syncytial virus vaccine in infants. J. Pediatr. 1976, 88, 931-936
9. Wright, P., Belshe, R., Kim, H., Voris, L.V. and Chanock, R. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect. Immun. 1982, 37, 397-400
10. Wathen, M., Brideau, R., Thomsen, D. and Murphy, B. Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. J. Gen. Virol. 1989, 70, 2625-2635
11. Wathen, M., Kakuk, T. and Brideau, R. et al. Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. J. Infect. Dis. 1991, 163, 477-482
12. Brideau, R., Walters, R., Stier, M. and Wathen, M. Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. J. Gen. Virol. 1989, 70, 2637-2644
13. Graham, B., Henderson, G. and Tang, Y. et al. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 1993, 1514, 2032-2040
14. + T lymphocytes in IFN-y production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 1991, 146, 286-292
15. Heinzel, P.P., Sadick, M.D., Holoday, B.J., Coffman, R.L. and Locksley, R.M. Reciprocal expression of Interferon-y or interleukin 4 during the resolution of progression of murine leishmaniasis: evidence of expansion of distinct helper T cell subsets. J. Exp. Med. 1989, 169, 59-72
16. + T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 1991, 147, 2713-2716
17. Romani, L., Mocci, S., Bietta, C., Lanfuloni, L., Puccetti, P. and Bistoni, F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 1991, 59, 4647-4654
18. Hancock, G., Speelman, D. and Frenchick, P. et al. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine 1994, 13, 391-400
19. + cytotoxic T lymphocyte responses. J. Immunol. 1992, 1488, 2357-2362
20. Wu, J., Gardner, B. and Murphy, C. et al. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 1992, 148, 1519-1525
21. Powell, M., Eastman, D. and Lim, A. et al. Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs. AIDS Res. Human Retro. 1995, 11, 203-209
22. Ivins, B., Welkos, S., Little, S., Crumrine, M. and Nelson, G. Immunization against Anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect. Immun. 1992, 60, 662-668
23. Garg, M. and Subbarao, B. Immune responses of systemic and mucosal lymphoid organs to Pnu-immune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant I. Infect. Immun. 1992, 60, 2329-2336
24. Zhou, F. and Huang, L. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes. Vaccine 1992, 11, 1139-1144
25. Graham, B.S., Perkins, M.D., Wright, P.F. and Karzon, D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 1988, 26, 153-162
26. Graham, B., Bunton, L., Wright, P. and Karzon, D. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 1991, 88, 1026-1033
27. Graham, B.S., Bunton, L.A., Wright, P.F. and Karzon, D.T. Reinfection of mice with respiratory syncytial virus. J. Med. Virol. 1991, 34, 7-13
28. Munoz, J., McCarthy, C., Clark, M. and Hall, C. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J. Virol. 1991, 65, 4494-4497
29. Cannon, M., Openshaw, P. and Askonas, B. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 1988, 168, 1163-1168